Health hazard evaluation report: HETA-83-113-1470, Raygo-Wagner, Portland, Oregon.
Authors
Apol AG; Helgerson S; Parrish RG
Source
Cincinnati, OH: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, HETA 83-113-1470, 1983 May; :1-25
Worker exposures to paint solvents were surveyed from December 30, 1982 to June 15, 1983 and on August 18 and 19, 1983 at Raygo Wagner (SIC-3531) in Portland, Oregon. The evaluation was requested by a former employee on behalf of himself and two other painters who suffered seizures and other neurologic problems. Personal and area air samples were collected for solvent vapors, and medical questionnaires were administered to two former and ten current employees. The composition of the solvents was also identified. Solvent exposure for one painter exceeded the NIOSH recommended 8 hour time weighted average limit, and exceeded the recommended short term limit for two painters. Nine of the workers reported difficulties with memory and thinking ability. Significant neurological or neuropsychological disturbances were found in five of the workers. Two of the five workers, and possibly a third, had symptoms of chronic toxic encephalopathy. Four other painters reported incidents of fainting on the job from solvent fume exposure. The authors note that changes in work processes and the use of protective equipment precluded evaluation of exposures that existed prior to the survey. They conclude that the neurologic disorders possibly were caused by excessive solvent exposure. No recommendations are offered since the factory has ceased production.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.